On-site Workshop

Enabling Next-Generation Implants with Evonik Biomaterials: A Materials & Processing Workshop

How can the performance and manufacturability of next-generation medical implants be advanced?

Join Evonik for a half-day workshop focused on high-performance biomaterials and processing technologies enabling innovation in implantable medical devices. Designed for engineers, R&D leaders, and manufacturing experts, this event will explore how advanced polymer platforms and processing expertise can help accelerate development while meeting stringent regulatory and performance requirements.

Key learnings for participants

Connect material science with real-world device manufacturing challenges. Here’s what you can expect:

  • Advanced Material Insights: 
    • RESOMER® bioresorbable polymers
    • VESTAKEEP® PEEK
    • VECOLLAN® and biocellic®, and their role in enabling innovative medical solutions.
    • Endexo® Surface Modification, a platform technology designed to help reduce:
      • Thrombus formation, supporting improved function and fewer complications
      • Bacterial adhesion, helping reduce biofilm formation, infection, and encrustation
      • Friction, resulting in lower device insertion forces
  • Processing Expertise: Gain practical understanding of micro molding and precision processing techniques critical for complex medical device components.
  • Application-Focused Learning: Discover how material selection and design impact device performance, manufacturability, and long-term outcomes.
  • Networking Opportunities: Engage with experts from industry and academia.

 


Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.


On-site Workshop details

Brit's Pub
1110 Nicollet Mall, Minneapolis, MN 55403
USA

English

on-site

Free of charge

October 27, 2026​

Register now

Our experts at the workshop

Registration

Fill out the form to register for the on-site workshop:

Agenda

The workshop will start at 11:00 a.m. on Tuesday, October 27, 2026, and finish at 3:00 p.m. on the same day. To see the detailed workshop program please click here.

11:30 am
Welcome & Introduction
Chander Chawla | Strategy, Business Development, P&L, Innovation @ Evonik 
11:35 am
TBA
Dr. Christopher H. Evans  | Principal Investigator, Musculoskeletal Gene Therapy Research; Lab Professor of Orthopedic Surgery; Professor of Physical Medicine and Rehabilitation @ Mayo Clinic
12:15 pm
RESOMER® Bioresorbable Polymers for Medical Devices
Mandy Wiermans | Senior Business Development Manager @ Evonik
12:55 pm
Coffee Break
01:10 pm
Advanced Micro Molding of PEEK, Bioresorbables, and Thermoplastics for Medical Applications
Vijay Kudchadkar | Director of Plastic and Sales Engineering @ Isometric Micro Molding – Nissha Medical Technologies
01:50 pm
Surface Modification Technology
Roger Lee | Business Development Manager, Medical Device Solutions @ Evonik
02:30 pm
High Performance Polymers
Matthew Cantwell | Business Development Manager, Medical PEEK @ Evonik
02:55 pm
Wrap-up & Networking
01:00 pm
Topic 8
Colleague | Job Title @ Evonik Health Care
01:30 pm
Wrap-Up and Goodbye
Colleague | Job Title @ Evonik Health Care
08:30 am
Registration & Light refreshments
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
09:00 am
Welcome & Introduction
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
09:10 am
Heterogeneous Catalysis in Flow Chemistry & Nickel Foam
Trevor Murray | Strategic Account Executive – Life Sciences @ Basetwo AI
10:30 am
Break
Trevor Murray | Strategic Account Executive – Life Sciences @ Basetwo AI
10:45 am
Overcoming the Selectivity Issue in a Nickel Catalyzed Batch Hydrogenation
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
11:30 am
Using Interfacial Charge Separation to Understand and Control Catalysis
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
12:15 pm
Lunch & Networking
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts

Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.

Questions?

Questions

Likhitha Bingham
Marketing Analyst
+1 256-783-9347

  • Evonik on social media